Endurant Capital Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-20,753
| Closed | -$291K | – | 47 |
|
2023
Q1 | $291K | Sell |
20,753
-705
| -3% | -$9.88K | 0.15% | 45 |
|
2022
Q4 | $307K | Sell |
21,458
-1,251
| -6% | -$17.9K | 0.12% | 51 |
|
2022
Q3 | $580K | Sell |
22,709
-306
| -1% | -$7.82K | 0.19% | 42 |
|
2022
Q2 | $654K | Buy |
+23,015
| New | +$654K | 0.23% | 41 |
|
2021
Q4 | – | Sell |
-29,838
| Closed | -$1.46M | – | 76 |
|
2021
Q3 | $1.46M | Buy |
+29,838
| New | +$1.46M | 0.33% | 43 |
|
2021
Q2 | – | Sell |
-58,168
| Closed | -$2.07M | – | 75 |
|
2021
Q1 | $2.07M | Buy |
+58,168
| New | +$2.07M | 0.54% | 49 |
|